MARATTO

article · Open Forum Infectious Diseases

Effect of the Scale-Up of Dolutegravir on Retention in Care, Risk of Developing Tuberculosis and Viral Load Suppression Among People Living With HIV: Analysis of Routine HIV Clinical Data in Rural KwaZulu-Natal, South Africa (2019–23)

Abstract

These findings support the sustained rollout of DTG-based regimens and emphasize the importance of continuous monitoring to assess their long-term associations and programmatic performance in comparable settings.

Research topics

  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • Tuberculosis Research and Epidemiology

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1093/ofid/ofag156

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.